These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 2198294

  • 1. Dose-response evaluation of the amnestic effects of triazolam and pentobarbital in normal subjects.
    Kirk T, Roache JD, Griffiths RR.
    J Clin Psychopharmacol; 1990 Jun; 10(3):160-7. PubMed ID: 2198294
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of triazolam and ethanol on awareness, memory, and psychomotor performance.
    Roache JD, Cherek DR, Bennett RH, Schenkler JC, Cowan KA.
    J Clin Psychopharmacol; 1993 Feb; 13(1):3-15. PubMed ID: 8486815
    [Abstract] [Full Text] [Related]

  • 3. Comparison of triazolam and pentobarbital: performance impairment, subjective effects and abuse liability.
    Roache JD, Griffiths RR.
    J Pharmacol Exp Ther; 1985 Jul; 234(1):120-33. PubMed ID: 2861282
    [Abstract] [Full Text] [Related]

  • 4. Triazolam impairs delayed recall but not acquisition of various everyday memory tasks in humans.
    Davis CM, Ambros-Ingerson J, Granger R, Wu J, Zabaneh R, Abdelnaby M, Lynch G.
    Exp Neurol; 1997 Nov; 148(1):124-34. PubMed ID: 9398455
    [Abstract] [Full Text] [Related]

  • 5. Morning amnestic effects of triazolam.
    Scharf MB, Kauffman R, Brown L, Segal JJ, Hirschowitz J.
    Hillside J Clin Psychiatry; 1986 Nov; 8(1):38-45. PubMed ID: 3744299
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects.
    Berlin I, Warot D, Hergueta T, Molinier P, Bagot C, Puech AJ.
    J Clin Psychopharmacol; 1993 Apr; 13(2):100-6. PubMed ID: 8463441
    [Abstract] [Full Text] [Related]

  • 7. Relative abuse liability of GHB in humans: A comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB.
    Carter LP, Richards BD, Mintzer MZ, Griffiths RR.
    Neuropsychopharmacology; 2006 Nov; 31(11):2537-51. PubMed ID: 16880774
    [Abstract] [Full Text] [Related]

  • 8. Acute effects of triazolam and lorazepam on human learning, performance and subject ratings.
    Rush CR, Higgins ST, Bickel WK, Hughes JR.
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1218-26. PubMed ID: 8450459
    [Abstract] [Full Text] [Related]

  • 9. Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability.
    Evans SM, Funderburk FR, Griffiths RR.
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1246-55. PubMed ID: 2262904
    [Abstract] [Full Text] [Related]

  • 10. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW, Suess PE, Griffiths RR.
    Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
    [Abstract] [Full Text] [Related]

  • 11. Relative abuse liability of indiplon and triazolam in humans: a comparison of psychomotor, subjective, and cognitive effects.
    Carter LP, Griffiths RR, Suess PE, Casada JH, Wallace CL, Roache JD.
    J Pharmacol Exp Ther; 2007 Aug; 322(2):749-59. PubMed ID: 17502431
    [Abstract] [Full Text] [Related]

  • 12. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
    Rush CR, Madakasira S, Goldman NH, Woolverton WL, Rowlett JK.
    J Pharmacol Exp Ther; 1997 Jan; 280(1):174-88. PubMed ID: 8996195
    [Abstract] [Full Text] [Related]

  • 13. Zolpidem and triazolam interact differentially with a delay interval on a digit-enter-and-recall task.
    Rush CR, Baker RW.
    Hum Psychopharmacol; 2001 Mar; 16(2):147-157. PubMed ID: 12404585
    [Abstract] [Full Text] [Related]

  • 14. Design and pharmacodynamic evaluation of novel dual release formulations of triazolam.
    Smith RB, Kroboth PD, Folan MM, Kroboth FJ, Rosanske TW.
    Int J Clin Pharmacol Ther Toxicol; 1993 Sep; 31(9):422-9. PubMed ID: 8225690
    [Abstract] [Full Text] [Related]

  • 15. A comparison of the single-dose effects of alprazolam, buspirone, and placebo upon memory function.
    Barbee JG, Black FW, Kehoe CE, Todorov AA.
    J Clin Psychopharmacol; 1991 Dec; 11(6):351-6. PubMed ID: 1770153
    [Abstract] [Full Text] [Related]

  • 16. Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers.
    Hallam KT, Olver JS, McGrath C, Norman TR.
    Hum Psychopharmacol; 2003 Dec; 18(8):619-25. PubMed ID: 14696021
    [Abstract] [Full Text] [Related]

  • 17. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: I. Comparison with triazolam in rhesus monkeys and rats.
    Rowlett JK, Woolverton WL.
    J Pharmacol Exp Ther; 1997 Jan; 280(1):162-73. PubMed ID: 8996194
    [Abstract] [Full Text] [Related]

  • 18. Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults.
    Lofwall MR, Griffiths RR, Mintzer MZ.
    Exp Clin Psychopharmacol; 2006 Nov; 14(4):439-49. PubMed ID: 17115871
    [Abstract] [Full Text] [Related]

  • 19. Sensitivity to triazolam in the elderly.
    Greenblatt DJ, Harmatz JS, Shapiro L, Engelhardt N, Gouthro TA, Shader RI.
    N Engl J Med; 1991 Jun 13; 324(24):1691-8. PubMed ID: 2034245
    [Abstract] [Full Text] [Related]

  • 20. Effects of donepezil on verbal memory after semantic processing in healthy older adults.
    FitzGerald DB, Crucian GP, Mielke JB, Shenal BV, Burks D, Womack KB, Ghacibeh G, Drago V, Foster PS, Valenstein E, Heilman KM.
    Cogn Behav Neurol; 2008 Jun 13; 21(2):57-64. PubMed ID: 18541979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.